AAUM (Average Assets Under Management) of ₹534.15 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.4% | 71.4% | ▼ -1.0% |
| Healthcare Services | 25.1% | 26.5% | ▲ +1.4% |
| Healthcare Equipment & Supplies | 1.2% | 1.0% | ▼ -0.2% |
| Insurance | 0.2% | 0.2% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.4% | 71.2% | ▼ -0.2% |
| Healthcare Services | 26.5% | 25.1% | ▼ -1.4% |
| Chemicals & Petrochemicals | 0.0% | 1.8% | ▲ +1.8% |
| Healthcare Equipment & Supplies | 1.0% | 0.6% | ▼ -0.3% |
| Insurance | 0.2% | 0.0% | ▼ -0.2% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹42.06 Cr |
Pharmaceuticals & Biotechnology | 6.16% |
| 2 | Jubilant Ingrevia Limited ₹12.51 Cr |
Chemicals & Petrochemicals | 1.83% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹36.96 Cr |
Pharmaceuticals & Biotechnology | 5.45% |
| 2 | Glenmark Pharmaceuticals Limited ₹11.02 Cr |
Pharmaceuticals & Biotechnology | 1.62% |
| 3 | Alkem Laboratories Limited ₹10.58 Cr |
Pharmaceuticals & Biotechnology | 1.56% |
| 4 | Medi Assist Healthcare Services Ltd ₹1.21 Cr |
Insurance | 0.18% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹56.39 Cr |
Pharmaceuticals & Biotechnology | 5.33% | 8.26% | +2.93% |
| 2 | Sun Pharmaceutical Industries Limited ₹101.52 Cr |
Pharmaceuticals & Biotechnology | 13.73% | 14.88% | +1.15% |
| 3 | Gland Pharma Limited ₹18.77 Cr |
Pharmaceuticals & Biotechnology | 2.21% | 2.75% | +0.54% |
| 4 | Laurus Labs Limited ₹18.16 Cr |
Pharmaceuticals & Biotechnology | 2.24% | 2.66% | +0.42% |
| 5 | Emcure Pharmaceuticals Limited ₹12.74 Cr |
Pharmaceuticals & Biotechnology | 1.49% | 1.87% | +0.38% |
| 6 | Sai Life Sciences Limited ₹21.04 Cr |
Pharmaceuticals & Biotechnology | 2.91% | 3.08% | +0.17% |
| 7 | Orchid Pharma Limited ₹12.83 Cr |
Pharmaceuticals & Biotechnology | 1.72% | 1.88% | +0.16% |
| 8 | Dr. Lal Path Labs Limited ₹8.38 Cr |
Healthcare Services | 1.07% | 1.23% | +0.16% |
| 9 | Rubicon Research Limited ₹14.91 Cr |
Pharmaceuticals & Biotechnology | 2.07% | 2.18% | +0.11% |
| 10 | Corona Remedies Limited ₹12.59 Cr |
Pharmaceuticals & Biotechnology | 1.74% | 1.85% | +0.11% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹9.66 Cr |
Pharmaceuticals & Biotechnology | 2.32% | 1.42% | -0.90% |
| 2 | Acutaas Chemicals Ltd ₹29.50 Cr |
Pharmaceuticals & Biotechnology | 5.20% | 4.32% | -0.88% |
| 3 | Max Healthcare Institute Limited ₹35.15 Cr |
Healthcare Services | 5.99% | 5.15% | -0.84% |
| 4 | Aurobindo Pharma Limited ₹11.06 Cr |
Pharmaceuticals & Biotechnology | 2.33% | 1.62% | -0.71% |
| 5 | Fortis Healthcare Limited ₹23.63 Cr |
Healthcare Services | 4.02% | 3.46% | -0.56% |
| 6 | Jubilant Pharmova Limited ₹9.38 Cr |
Pharmaceuticals & Biotechnology | 1.93% | 1.37% | -0.56% |
| 7 | Zydus Lifesciences Limited ₹8.45 Cr |
Pharmaceuticals & Biotechnology | 1.64% | 1.24% | -0.40% |
| 8 | EQ - LAXMI DENTAL LIMITED ₹4.35 Cr |
Healthcare Equipment & Supplies | 0.95% | 0.64% | -0.31% |
| 9 | Yatharth Hospital & Trauma Care Serv Ltd ₹20.38 Cr |
Healthcare Services | 3.15% | 2.99% | -0.16% |
| 10 | Krishna Institute Of Medical Sciences Limited ₹20.12 Cr |
Healthcare Services | 3.09% | 2.95% | -0.14% |
32 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹101.52 Cr |
Pharmaceuticals & Biotechnology |
14.88%
|
|
| 2 |
₹56.39 Cr |
Pharmaceuticals & Biotechnology |
8.26%
|
|
| 3 |
₹42.06 Cr |
Pharmaceuticals & Biotechnology |
6.16%
|
|
| 4 |
₹35.15 Cr |
Healthcare Services |
5.15%
|
|
| 5 |
₹29.50 Cr |
Pharmaceuticals & Biotechnology |
4.32%
|
|
| 6 |
₹29.46 Cr |
Pharmaceuticals & Biotechnology |
4.32%
|
|
| 7 |
₹26.34 Cr |
Healthcare Services |
3.86%
|
|
| 8 |
₹23.63 Cr |
Healthcare Services |
3.46%
|
|
| 9 |
₹22.23 Cr |
Pharmaceuticals & Biotechnology |
3.26%
|
|
| 10 |
₹21.04 Cr |
Pharmaceuticals & Biotechnology |
3.08%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.